Scarica l'app Stockscreener
156.87
0.60%
-0.95
Dopo l'orario di chiusura:
156.87
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Insmed Inc Borsa (INSM) Ultime notizie
Bank of New York Mellon Corp Trims Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed (INSM) Sees Surge in Bullish Option Activity - GuruFocus
Morgan Stanley Updates Rating for Insmed (INSM), Adjusts Price T - GuruFocus
New York State Common Retirement Fund Buys 18,123 Shares of Insmed, Inc. $INSM - MarketBeat
What Insmed (INSM)'s Upcoming TPIP Data and New Analyst Coverage Mean For Shareholders - Yahoo Finance
Insmed TPIP Data At PVRI 2026 Tests Pulmonary Arterial Hypertension Ambitions - Yahoo Finance
Insmed (NASDAQ:INSM) Coverage Initiated at Barclays - MarketBeat
Definium Therapeutics Appoints Roger Adsett To Board - citybiz
Definium Therapeutics Appoints Roger Adsett to Board of Directors, Effective from January 29, 2025 - marketscreener.com
Definium Therapeutics Appoints Roger Adsett to Board of Directors - Business Wire
Barclays Initiates Coverage on Insmed With Overweight Rating, $231 Price Target - marketscreener.com
Barclays Initiates Coverage on Insmed (INSM) with Overweight Rat - GuruFocus
Insmed to Present Multiple Abstracts on Treprostinil Palmitil Inhalation Powder (TPIP) at Pulmonary Vascular Research Institute (PVRI) 2026 Congress - PR Newswire
Mutual of America Capital Management LLC Lowers Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Strs Ohio Grows Stake in Insmed, Inc. $INSM - MarketBeat
Does Insmed Incorporated have strong fundamentalsJuly 2025 News Drivers & AI Based Buy and Sell Signals - baoquankhu1.vn
Pulmonary Arterial Hypertension Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Ribomic, Gmax Biopharm, Novartis, Cereno Scientific AB, Insmed - Barchart.com
Universal Beteiligungs und Servicegesellschaft mbH Trims Stake in Insmed, Inc. $INSM - MarketBeat
Insmed Incorporated (INSM) Stock Analysis: Potential 37% Upside Amid Robust Revenue Growth - DirectorsTalk Interviews
Setup Watch: What is ROIVs book value per shareWall Street Watch & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Insmed, Inc. $INSM Stock Holdings Lessened by Emerald Mutual Fund Advisers Trust - MarketBeat
Roth Capital Initiates Coverage of Insmed (INSM) with Buy Recommendation - Nasdaq
Stifel Initiates Insmed(INSM.US) With Buy Rating, Announces Target Price $212 - 富途资讯
Roth Capital Initiates Coverage on Insmed (INSM) with Buy Rating - GuruFocus
Roth/MKM initiates Insmed stock with Buy rating, $212 price target - Investing.com Canada
Insmed (INSM) chair and CEO Lewis sells $1.7M in stock - Investing.com
Insmed (INSM) chair and CEO Lewis sells $1.7M in stock By Investing.com - Investing.com Nigeria
Insider Selling: Insmed (NASDAQ:INSM) CEO Sells 10,699 Shares of Stock - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed IncorporatedINSM - PR Newswire
Breaking Down Insmed: 18 Analysts Share Their Views - Benzinga
Insmed stock price target raised to $200 by RBC on Brinsupri success - Investing.com Canada
RBC Capital Raises Price Target for Insmed (INSM) to $200 | INSM Stock News - GuruFocus
Analyst weighs patent cliff risks against Insmed’s (INSM) growth story - MSN
What are the risks of holding Insmed IncorporatedTrade Ideas & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Market Review: Is Insmed Incorporated stock a smart retirement pick2025 Performance Recap & Consistent Growth Equity Picks - baoquankhu1.vn
Insmed Inc (INSM US): Brinsupri on High Trajectory; Multiple Readouts to Make 2026 a Pivotal Year - Smartkarma
Aug Reactions: Does Capital Growth Mortgage Investors L P Preferred Security have strong EBITDA marginsPortfolio Return Summary & High Conviction Buy Zone Alerts - baoquankhu1.vn
Aug Closing: What are the risks of holding Insmed Incorporated2025 Growth vs Value & Reliable Entry Point Alerts - baoquankhu1.vn
Analyst Weighs Patent Cliff Risks Against Insmed's (INSM) Growth Story - Finviz
Insmed, Inc. (NASDAQ:INSM) Short Interest Up 23.4% in December - MarketBeat
Analyst Weighs Patent Cliff Risks Against Insmed’s (INSM) Growth Story - Insider Monkey
Oak Ridge Investments LLC Sells 12,052 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed sinks after brensocatib fails trial for sinus condition - MSN
Campbell & CO Investment Adviser LLC Invests $2.75 Million in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. (NASDAQ:INSM) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Analysts’ Top Healthcare Picks: Insmed (INSM), Roche Holding AG (RHHVF) - The Globe and Mail
EULAV Asset Management Acquires Shares of 90,000 Insmed, Inc. $INSM - MarketBeat
Looking At Insmed's Recent Unusual Options Activity - Benzinga
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed IncorporatedINSM - marketscreener.com
Nisa Investment Advisors LLC Acquires 8,261 Shares of Insmed, Inc. $INSM - MarketBeat
Aug Reactions: Can Insmed Incorporated expand into new markets2025 Price Action Summary & Short-Term High Return Strategies - baoquankhu1.vn
SG Americas Securities LLC Acquires 13,305 Shares of Insmed, Inc. $INSM - MarketBeat
Jobs Data: What is the long term forecast for Insmed Incorporated stockJuly 2025 Earnings & Safe Capital Allocation Plans - baoquankhu1.vn
Analysts Have Conflicting Sentiments on These Healthcare Companies: Establishment Labs Holdings (ESTA), Sarepta Therapeutics (SRPT) and Insmed (INSM) - The Globe and Mail
Insmed CEO William Lewis sells $3.2 million in shares By Investing.com - Investing.com South Africa
Insmed CEO William Lewis sells $3.2 million in shares - Investing.com
2.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):